Choroidal Neovascular Membrane,
Showing 1 - 25 of 3,017
Optical Coherence Tomography Angiography Criteria Of The
Not yet recruiting
- Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
- Optical coherence tomography angiography
- (no location specified)
Sep 27, 2022
OCTA Insights in CNVM, Morphological Characteristics and
Not yet recruiting
- Choroidal Neovascularization
- (no location specified)
Sep 14, 2021
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Deep Learning OCT and OCTA in NVC
Recruiting
- Macular Degeneration Choroidal Neovascularization
- Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
-
Naples, ItalyFederico II University
Aug 3, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- Aflibercept(BAY86-5321, Eylea)
- (no location specified)
Jul 22, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion With Macular Edema Trial in Makati
Completed
- Neovascular Age-related Macular Degeneration
- +4 more
- Intravitreal injection guide (Malosa)
- Dual Blade Eyelid Speculum
-
Makati City, MM, PhilippinesPeregrine Eye and Laser Instittute
Apr 25, 2021
Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)
Recruiting
- Macular Degeneration, Choroidal Neovascularization
- episcleral brachytherapy
-
'Aiea, Hawaii
- +1 more
Feb 11, 2022
Photobiomodulation, Age-Related Macular Degeneration Trial (Valeda machine)
Not yet recruiting
- Photobiomodulation
- Age-Related Macular Degeneration
- Valeda machine
- (no location specified)
Aug 22, 2022
Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, ArizonaRetinal Research Institute, LLC
Jun 4, 2023
Neovascular Age-Related Macular Degeneration (nAMD) Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Ranibizumab
Recruiting
- Neovascular Age-Related Macular Degeneration (nAMD)
- RGX-314 Dose 1
- +3 more
-
Phoenix, Arizona
- +14 more
Mar 29, 2022
Wet Macular Degeneration Trial in Los Angeles (Aflibercept Ophthalmic, optovue angiovue)
Completed
- Wet Macular Degeneration
- Aflibercept Ophthalmic
- optovue angiovue
-
Los Angeles, CaliforniaStein Eye Institute of UCLA
Dec 9, 2021
Neovascular Age-related Macular Degeneration Trial (dose 1 IBI302, Aflibercept, dose 2 IBI302)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- dose 1 IBI302
- +2 more
- (no location specified)
May 26, 2022
Defining Disease Activity in Neovascular AMD With Optical
Recruiting
- Neovascular Age-related Macular Degeneration
-
London, United KingdomMoorfields Eye Hospital NHS Foundation Trust, 162 City Road
Aug 19, 2021
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Hurstville, New South Wales, Australia
- +8 more
May 7, 2021
Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)
Completed
- Choroidal Neovascularization
-
Sao Paulo, BrazilHospital das Clínicas- University of Sao Paulo
Jan 4, 2022
Neovascular Age-Related Macular Degeneration, Choroidal Neovascularization Trial (Brolucizumab ophthalmic solution, Aflibercept
Completed
- Neovascular Age-Related Macular Degeneration
- Choroidal Neovascularization
- Brolucizumab ophthalmic solution
- Aflibercept ophthalmic solution
- (no location specified)
Sep 9, 2020
Vogt Koyanagi Harada Disease Trial in São Paulo (Early high-dose corticosteroid and immunosuppressive therapy)
Recruiting
- Vogt Koyanagi Harada Disease
- Early high-dose corticosteroid and immunosuppressive therapy
-
São Paulo, SP, BrazilHospital das Clinicas HCFMUSP, Faculdade de Medicina Universidad
Jan 4, 2022
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Tucson, Arizona
- +49 more
Feb 15, 2022
Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in
Recruiting
- Central Serous Chorioretinopathy
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 25, 2021
OCT Angiography in Wet AMD
Recruiting
- Neovascular (Wet) Age-related Macular Degeneration (AMD)
- Optical Coherence Tomography
-
Portland, OregonCasey Eye Institute, Oregon Health & Science University
Sep 20, 2022
Neovascularization, Choroidal, Macular Degeneration, Age-Related Trial in United States (Faricimab, Ranibizumab, Sham Procedure)
Completed
- Neovascularization, Choroidal
- Macular Degeneration, Age-Related
- Faricimab
- +2 more
-
Phoenix, Arizona
- +24 more
Dec 9, 2020
Neovascular Age Related Macular Degeneration Trial in France (RTH258/Brolucizumab)
Active, not recruiting
- Neovascular Age Related Macular Degeneration
-
Nice, Cedex1, France
- +39 more
Jan 20, 2023
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023